Samreen Rehman
August 14, 2026
Digital Biomarkers: Transforming the Future of Clinical Research

Digital biomarkers are emerging as one of the most promising innovations in clinical research, offering a smarter and more objective way to monitor patient health. Unlike traditional biomarkers that rely on laboratory tests or occasional clinical assessments, digital biomarkers are generated through data collected by wearable devices, smartphones, mobile applications, and connected sensors. These technologies continuously capture health-related information such […]

Read More
Role of Clinical Research Organisations in India's Pharma Growth Story
August 5, 2026
The Role of Clinical Research Organisations in India’s Pharma Growth Story

India’s pharmaceutical industry is one of the largest in the world by volume. It supplies generic medicines, vaccines, and active pharmaceutical ingredients to more than 200 countries. Behind this growth story, a lesser known but very important player has been at work: the clinical research organisation in India.  These organisations help pharma and biotech companies test new drugs, manage clinical […]

Read More
July 17, 2026
Clinical Safety: The Foundation of Trust in Clinical Research

How proactive safety oversight protects participants, strengthens data integrity, and supports successful clinical development  Clinical research is built on a commitment—to advance medical science while safeguarding the individuals who make that progress possible. Every participant who enrolls in a clinical trial places trust in the research team, sponsor, and broader clinical development ecosystem. Clinical safety is how that trust is upheld every […]

Read More
Navigating CDSCO Approvals
July 13, 2026
Navigating CDSCO Approvals: How a Clinical Research Organization in India Simplifies Regulatory Timelines for Drug Trials

For any pharmaceutical company planning to run a clinical trial in India, the approval process from the Central Drugs Standard Control Organisation (CDSCO) is often the first major hurdle. Delays at this stage can push back study start dates by months, increase costs, and put entire development timelines at risk. This is one of the […]

Read More
July 9, 2026
From the Founder’s Desk | Dr. Devesh Kumar | Founder & MD, Innovate Research

Your Ingredient May Be Clinically Proven… But Is Your Product?  The nutraceutical industry is evolving rapidly. Consumers today are more informed, healthcare professionals are asking tougher questions, and brands are competing in an increasingly crowded marketplace. In this environment, simply stating that an ingredient is “clinically proven” is no longer enough.  One of the most common approaches adopted by […]

Read More
July 2, 2026
From the Founder’s Desk | Dr. Devesh Kumar | Founder & MD, Innovate Research

Consumer Perception Studies: The Missing Link Between Science and Market Success  The Indian nutraceutical industry is growing rapidly, with new products entering the market almost every day. While companies invest significantly in research, formulation, and clinical validation, one critical aspect is often overlooked—how consumers actually perceive the product.  A product may have excellent scientific evidence, but if […]

Read More
How Mumbai CROs Are Reducing Patient Recruitment Timelines in 2026
June 29, 2026
How Mumbai CROs Are Reducing Patient Recruitment Timelines in 2026

Patient recruitment is one of the biggest challenges in clinical trials. According to NIH, nearly 80% of trials fail to meet their enrolment deadlines. This delay pushes back drug approvals, increases costs, and ultimately slows down access to life-saving treatments.  However, in 2026, things are changing. A growing number of sponsors are turning to a clinical research organisation in India to speed up recruitment without compromising data quality […]

Read More
CRO Solving Patient Recruitment Challenges in Clinical Trials
December 20, 2025
How Contract Research Organizations in India Are Solving Patient Recruitment Challenges in Clinical Trials

Clinical trials are the backbone of medical innovation. They are the gateway through which new therapies are proven safe and effective before reaching patients. Yet, one of the most persistent and costly challenges facing biopharma sponsors today is patient recruitment.  Around the world, an estimated 70–85% of clinical trials fail to meet enrolment targets on time, with many struggling to recruit […]

Read More